These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37149156)

  • 1. Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring.
    Oda K; Saito H; Jono H
    Pharmacol Ther; 2023 Jun; 246():108433. PubMed ID: 37149156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
    Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
    Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
    Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
    JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients.
    Mena M; Garcia JC; Bustos RH
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
    Suttels V; André P; Thoma Y; Veuve F; Decosterd L; Guery B; Buclin T
    JAC Antimicrob Resist; 2022 Apr; 4(2):dlac043. PubMed ID: 35465238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin therapeutics and monitoring: a contemporary approach.
    Avent ML; Vaska VL; Rogers BA; Cheng AC; van Hal SJ; Holmes NE; Howden BP; Paterson DL
    Intern Med J; 2013 Feb; 43(2):110-9. PubMed ID: 23185970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Schatz LM; Brinkmann A; Röhr A; Frey O; Greppmair S; Weinelt F; Zoller M; Scharf C; Hempel G; Liebchen U
    Antimicrob Agents Chemother; 2023 May; 67(5):e0010423. PubMed ID: 37125925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring.
    Chen A; Gupta A; Do DH; Nazer LH
    Pharmacol Res Perspect; 2022 Dec; 10(6):e01026. PubMed ID: 36398492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
    Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
    Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-Loop Control for Precision Antimicrobial Delivery: An In Silico Proof-of-Concept.
    Herrero P; Rawson TM; Philip A; Moore LSP; Holmes AH; Georgiou P
    IEEE Trans Biomed Eng; 2018 Oct; 65(10):2231-2236. PubMed ID: 29989937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dosing and monitoring of vancomycin: what is the best way forward?
    Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
    Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results.
    Kim B; Hwang S; Heo E; Kim HS; Jung J; Kim ES; Kim HB; Lee K; Park JS; Song J; Lee JH; Chung JY; Song KH; Yoon S
    J Korean Med Sci; 2023 Apr; 38(14):e101. PubMed ID: 37038640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
    Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
    Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
    Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
    Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system.
    Oliver MB; Boeser KD; Carlson MK; Hansen LA
    Am J Health Syst Pharm; 2023 May; 80(11):670-677. PubMed ID: 36860169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital.
    Frymoyer A; Schwenk HT; Zorn Y; Bio L; Moss JD; Chasmawala B; Faulkenberry J; Goswami S; Keizer RJ; Ghaskari S
    Front Pharmacol; 2020; 11():551. PubMed ID: 32411000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
    Fewel N
    J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.
    Giuliano C; Haase KK; Hall R
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):95-106. PubMed ID: 20014904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.